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Abstract
Background. Acute peritonitis is the most frequent com-
plication of peritoneal dialysis (PD). Increased nitric oxide
(NO) release by NO synthase (NOS) isoforms has been im-
plicated in acute peritonitis, but the role played by the NOS
isoforms expressed in the peritoneum is unknown.
Methods.Weinvestigatedthestructuralandfunctionalcon-
sequences of acute peritonitis induced by LPS in wild-type
(WT) mice versus knockout mice (KO) for the endothelial
NOS (eNOS), the inducible NOS (iNOS) or the neuronal
NOS (nNOS).
Results.ThelevelofNOmetabolites(NOx)inthedialysate
was maximal 18 h after LPS injection. LPS induced a sig-
nificant increase in the transport of small solutes and de-
creased ultrafiltration in WT mice. These changes, which
occurred without vascular proliferation, were paralleled by
the upregulation of nNOS and eNOS, and the induction of
iNOS. The transport modifications induced by LPS were
significantly reversed in eNOS KO mice, but not modified
in mice lacking iNOS or nNOS. In contrast, the increase
of dialysate NOx was abolished in iNOS KO mice and sig-
nificantly reduced in eNOS KO mice, but left unchanged
in mice lacking nNOS. Mice lacking iNOS also showed
more severe inflammatory changes, and a trend towards
increased mortality following LPS.
Conclusion.ThesedatademonstratespecificrolesforNOS
isoforms in the peritoneal membrane and suggest that se-
lective eNOS inhibition may improve peritoneal transport
during acute peritonitis.
Keywords: acute peritonitis; knockout mice; LPS; NO synthases;
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Introduction
Nitric oxide (NO) plays an essential role in a variety of
processes including regulation of blood flow and vascu-
lar permeability, mucosal defence, leukocyte recruitment,
immune regulation and neurotransmission. Three distinct
NO synthase (NOS) isoforms are involved in the synthesis
of NO from L-arginine. The neuronal (nNOS, NOS1) and
endothelial (eNOS, NOS3) NOS are constitutive, calcium-
dependent isoforms. nNOS, which was first located in the
central and peripheral nervous system, is also detected in
non-neuronal cells, including myocytes, epithelial cells,
mast cells and neutrophils [1–4]. eNOS, first and foremost
identifiedinendothelialcells,isalsoexpressedinepithelial
cells, smooth muscle cells and T lymphocytes [5–7]. The
calcium-independent, inducible isoform (iNOS, NOS2) is
expressed in many cell types, including macrophages and
endothelialcells,andisinducedbyinflammatorycytokines
and bacterial metabolites such as lipopolysaccharide (LPS)
[8].
Acuteperitonitisremainsthemostfrequentcomplication
of peritoneal dialysis (PD) [9]. Early studies by Krediet and
colleagues have shown increased NO levels in the dialysate
during acute peritonitis [10,11], which prompted us to in-
vestigatethemolecular basisoftheproductionofNOinthe
peritoneum.WefirstdemonstratedspecificNOSactivityin
the peritoneal membrane, due to the expression of the three
NOS isoforms [12,13]. Under baseline conditions, eNOS is
the predominant NOS isoform in the peritoneum, reflect-
ing the endothelial component of the membrane. During
acute peritonitis, there is a selective upregulation of both
endothelial and inducible NOS isoforms, in parallel with
structural modifications that include increased endothelial
area and mononuclear cell infiltrate [10,12].
The role played by NO during peritonitis has been in-
vestigated in rat and mouse models using a 6-day model
of catheter-induced peritonitis [14,15]. In this model, acute
peritonitis was reflected by functional modifications, in-
cluding increased transport for small solutes, faster glu-
cose reabsorption and loss of ultrafiltration (UF), which
were attributed to increased effective peritoneal surface
area (EPSA) due to capillary recruitment and/or vas-
cular proliferation [10,12]. Pharmacological studies with
the non-specific NOS inhibitor NG-nitro-L-arginine methyl
ester (L-NAME) [14] as well as studies using eNOS
C   The Author 2009. Published by Oxford University Press [on behalf of the ERA-EDTA]. This is an Open Access article distributed under the terms of the Creative
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Fig.1. TimecourseofdialysateNOxlevelsinLPS-treatedmice.Thetotal
dialysate NOx (nitrate + nitrite) levels were measured using the Griess
reaction. There were at least four mice at each time point. P < 0.001
(ANOVA); ∗P < 0.05 Tx versus T0.
knockout (KO) mice [15] demonstrated that the eNOS-
derived NO was instrumental in the structural (vascular
proliferation) and functional (hyperpermeability) modifi-
cations induced by acute peritonitis. However, these studies
did not address the potential role(s) of other NOS isoforms
in the peritoneal membrane and could not discriminate be-
tweenthestructuralandfunctionaleffectsintheearlyphase
ofacuteperitonitis—whenvascularproliferationhasnotyet
occurred. Recent studies, based on the effect of L-NAME
in a LPS-induced peritonitis mouse model [16], suggested
that NO could play a role in the modifications of transport
parameters in the early phase of peritonitis, in the absence
of vascular proliferation. However, the latter investigation,
performed in wild-type mice, could not address the con-
tributions of the three different NOS isoforms in transport
and structural changes in the peritoneum.
In the present study, we have used transgenic mouse
models to provide direct evidence for a specific role of
each NOS isoform in the functional changes and release of
NO metabolites associated with acute peritonitis induced
by LPS.
Material and methods
Animals, experimental groups and acute peritonitis model
Experiments were performed on adult male C57 BL/6J mice (Iffa Credo,
Brussels,Belgium)andeNOS,iNOSandnNOSmice(allontheC57BL/6J
background). Mice lacking eNOS (eNOS KO) and their wild-type litter-
mates (eNOS WT) were generated as described previously [17] and ob-
tained from the Jackson Laboratory (Bar Harbor, ME, USA). The iNOS
WT and KO mice [18] were obtained from P. Brouckaert (Ghent Univer-
sity, Ghent, Belgium). The nNOS KO and WT mice [19] were obtained
from B. Casadei (University of Oxford, Oxford, UK). All animals had
access to appropriate standard diet and tap water ad libitum. The exper-
iments were approved by the local Ethics Committee and conducted in
accord with the NIH Guide for the Care and Use of Laboratory Animals.
The first series of experiments were performed on C57 BL/6J mice,
including the LPS time-course study (n = 24 mice) and the investigation
of transport parameters and structural changes at baseline and following
LPStreatment(n=14pairsofmice).Inasecondroundofexperiments,at
leastsixpairsofeNOSmice,iNOSmiceandnNOSmicewereinvestigated
during LPS-induced acute peritonitis, in comparison with WT mice under
control conditions. Acute peritonitis was generated by i.p. injection of
LPS (10 mg/kg, Escherichia coli serotype O111: B4, Sigma). Eighteen
hours after LPS injection, all mice underwent a peritoneal equilibration
test (PET) as described below.
Table 1. Clinical and biological parameters in the NOS isoform mice
Body Haematocrit Dialysate WBC MAP
NOS isoform N weight (g) (%) (×104/mL) (mmHg)
eNOS
WT 5 27 ± 14 7 ± 16 8 ± 38 2 ± 3
WT-LPS 5 22 ± 0.5 47 ± 1 138 ± 22a 78 ± 5
KO-LPS 5 21 ± 0.5 49 ± 1 119 ± 10a 87 ± 2
nNOS
WT 5 29 ± 0.5 46 ± 16 8 ± 78 2 ± 3
WT-LPS 5 30 ± 15 3 ± 2 158 ± 9b 73 ± 2
KO-LPS 4 28 ± 0.5 46 ± 2 219 ± 48b 75 ± 4
iNOS
WT 5 27 ± 14 8 ± 45 1 ± 58 1 ± 2
WT-LPS 4 28 ± 0.5 51 ± 2 155 ± 11c 74 ± 2
KO-LPS 5 26 ± 15 4 ± 1 285 ± 46c,d 77 ± 3
WBC, white blood cells; MAP, mean arterial blood pressure; WT, wild-
type mice; WT-LPS, LPS-induced peritonitis in wild-type mice; KO-LPS,
LPS-induced peritonitis in knockout mice.
The parameters in peritonitis groups were recorded at 18 h after LPS
injection.
aP<0.05versuseNOSWTmice; bP<0.05versusnNOSWTmice; cP<
0.05 versus iNOS WT mice; dP < 0.05 versus iNOS WT-LPS mice.
Peritoneal transport studies, tissue sampling
A peritoneal equilibration test (PET) was used to investigate peritoneal
transport parameters in mice as previously described [20]. Briefly, after
anaesthesiawithketamineandxylazine,micewereplacedonathermopad
at 37◦C and catheterized for blood pressure monitoring (right common
carotid artery) and saline infusion (right jugular vein, 0.9% NaCl, 0.3 mL/
h). After 30 min, a silicon catheter (Venflon 22 GA, Baxter) was inserted
intotheperitonealcavityand2.0mLof7%dialysate(Dianeal;Baxter)was
instilled [20]. Blood and dialysate samples (50–100 µL) were taken from
carotid artery and the PD catheter at time 0 and at 30 min, 60 min, and 120
min of dwell time. Haematocrit was measured before PD exchange. At the
end of the dwell, the dialysate was recovered from the peritoneal cavity
and net UF was calculated [15,20]. Dialysate white blood cells (WBCs)
were counted using a haemocytometer (Marienfeld, Lauda, Germany) and
the differential count (macrophages, neutrophils and lymphocytes) was
established after Wright-Giemsa staining (Sigma) following the manufac-
turer’s instruction. The mice were exsanguined and urea, glucose, sodium
andtotalproteinwereassayed usingKodakEktachemDT60IIandDTEII
analysers (Eastman Kodak Company, Rochester, NY, USA). Peritoneum
samples were carefully dissected and processed for fixation and protein
extraction as described previously [12–15]. Samples from the visceral and
parietal peritoneum were fixed for 3 h at 4◦C in 4% paraformaldehyde in
a 0.1 M phosphate buffer, rinsed and embedded in paraffin. Samples from
the visceral peritoneum were dissected, snap-frozen in liquid nitrogen and
stored at −80◦C.
Antibodies
The NOS isoforms were detected with well-characterized monoclonal an-
tibodies against eNOS, nNOS and iNOS (Transduction laboratories, Lex-
ington, KY) [13,15]. Other antibodies included a goat antibody against
CD31 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and a mono-
clonal antibody against β-actin (Sigma, St. Louis, MO, USA).
Immunoblotting analyses
SDS–PAGE and immunoblotting were performed as described [12,13,15].
Protein extracts from the visceral peritoneum were separated on 7.5%
acrylamide slabs and transferred to nitrocellulose. Efficiency of transfer
to nitrocellulose was tested by Ponceau red (Sigma) staining and im-
munoreactivity for β-actin. The membranes were blocked for 30 min,
incubated overnight with the primary antibody at 4◦C, washed, incubated
for 1 h with peroxidase-labelled secondary antibodies (Dako, Glostrup,
Denmark) and visualized with enhanced chemiluminescence (Amersham,
Little Chalfont, UK). The immunoblots were performed at least in du-
plicate, and specificity of the signal was determined by comparison with
positive controls. Densitometry analysis was performed with a StudioStar88 J. Ni et al.
Fig. 2. Effects of LPS-induced peritonitis on the peritoneum: morphology. Haemalun–eosine staining in the visceral (A, B, E and F) and parietal (C
and D) peritoneum of control (A, C and E) or LPS-treated mice (B, D and F). LPS-induced peritonitis is reflected by an inflammatory infiltrate in the
visceral (B) and parietal (D) peritoneum. Marginating and perivascular leukocytes are clearly identified in LPS-treated mice (F).
Scanner (Agfa-Gevaert, Mortsel, Belgium) using the NIH-Image V1-57
software.
Tissue staining and immunohistochemistry
Haematoxylin and eosin (HE) staining and immunostaining were per-
formed as described previously [12,14,15]. After blocking in 0.3% H2O2
andincubationwith10%normalserum,sectionswereincubatedfor45min
eachwiththeprimaryantibody,biotinylatedIgGandavidin–biotinperoxi-
dase(VectorLaboratories,Burlingame,CA,USA).TheMOMimmunode-
tection kit (Vector) was used for monoclonal antibodies. Immunolabelling
was visualized using aminoethylcarbazole (Vector). Sections were viewed
under a Leica DMR coupled with a Leida DC 300 camera (Leica, Heer-
brugg, Switzerland). The specificity of immunolabelling was confirmed
byincubationwithoutprimaryantibodyandwithnonimmuneIgG(Dako).
Microvascular density was assessed using CD31 immunostaining, as pre-
viously reported in detail [21]. Sections were digitalized to measure the
density of vascular structures (in N vessels/mm2) and the relative
endothelial area (i.e. the ratio between the cumulative endothelial area
and the peritoneum area) as described [15,22]. All slides were coded and
analysed by the same operator. The analysis included a mean of 10 fields
per sample and four mice in each group. The intensity of the inflamma-
tory reaction in the visceral peritoneum in four pairs of randomly selected
iNOS mice was graded as follows: 0, absence of rolling; 1, rolling; 2, mild
infiltrate (perivascular and/or interstitial); 3, severe infiltrate (perivascular
and/or interstitial).
Determination of nitrite/nitrate (NOx)
The production of nitrite and nitrate in the dialysate was measured us-
ing a colorimetric assay based on the Griess reaction [15], following the
manufacturer’s instructions (Cayman Chemical, Ann Arbor, MI, USA).
Data analysis
Data are presented as mean ± SEM. Statistical analyses were per-
formed using ANOVA and the appropriate parametric (Bonferroni) orRole of NOS isoforms in LPS peritonitis 89
Fig. 3. LPS induction of eNOS and nNOS in the peritoneum: immunostaining. Immunostaining for eNOS (A and B) and nNOS (C–F) in the visceral
peritoneum of control (A, C and E) and LPS-treated mice (B, D and F). Immunoreactivity for eNOS is located in the endothelium lining peritoneal
blood vessels in control mice (A). The staining intensity of blood vessels stained for eNOS is markedly increased in LPS-treated mice with peritonitis
(B). Immunoreactivity for nNOS is located in the scattered nuclei of visceral peritoneum in control mice (C) and is over-expressed in endothelial cells,
nerve sections and perivascular inflammatory cells (D and F) in LPS-induced peritonitis.
non-parametric (Mann–Whitney) test for multiple comparisons (Graph-
Pad Software, San Diego, CA, USA).
Results
Effect of LPS on C57 BL/6J mice
Effect of LPS on NOx level in the dialysate: time-course
analysis. Once released in biological fluids, NO is ox-
idized to the inactive and stable metabolites NO2/NO3
(NOx),whichcanbequantifiedasasurrogatemarkerofNO
production [23]. Treatment with LPS induced a significant
increaseintheNOxlevelindialysate(Figure1).Theinduc-
tion was time dependent, reaching a maximum between 12
and 24 h, with a sharp decrease thereafter. Sequential anal-
ysis of the differential WBC count confirmed that this time
course corresponded to a majority of macrophages (55 ±
2% at 12 h and 50 ± 3% at 18 h, N = 4 mice for each
time-point) in the dialysate, before the characteristic neu-
trophil invasion was observed after 24 h (data not shown).
Accordingly, most analyses were performed 18 h after LPS
treatment.
Morphological characteristics of LPS-induced peritonitis.
Morphological examination of the visceral and parietal
peritoneum (HE staining) showed that, in comparison with
control mice, LPS-induced acute peritonitis was reflected
by a discrete infiltrate of inflammatory cells in both the90 J. Ni et al.
Fig. 4. LPS induction of NOS isoforms: immunoblotting. Representative immunoblots for nNOS, eNOS and iNOS in peritoneum extracts prepared
from control mice and LPS-treated mice (20 µg protein/lane). The blots were stripped and reprobed for β-actin for loading accuracy. A consistent
upregulation of nNOS (155 kD) and eNOS (140 kD) is detected in LPS-treated mice. The signal for iNOS (130 kD, lower band of the blot) is not
detected in control samples but appears in LPS-treated mice. Densitometry analysis confirms the major upregulation of nNOS (relative optical density:
1170 ± 200%, ∗P = 0.005) and eNOS (relative optical density : 247 ± 110%, ∗P = 0.01) following LPS.
Fig. 5. Peritoneal infiltrate in iNOS mice. Haemalun–eosine staining in the visceral peritoneum (A) of LPS-treated iNOS WT mice (upper panel) and
iNOS KO mice (lower panel). LPS-induced peritonitis is reflected by a discrete inflammatory infiltrate, which is markedly more severe in iNOS KO
mice. The infiltrate score (B) is significantly increased in LPS-treated iNOS KO mice (P < 0.01 versus iNOS WT mice, n = 6).
visceral (Figure 2A,B) and parietal peritoneum (Figure 2C,
D). The leukocytes infiltrate started at the early stage of
inflammation. Six hours after LPS injection, the majority
of inflammatory cells were polymorphonuclear leukocytes,
mostly located in the capillary lumen. At 18 h, marginating
leukocytes were observed in the capillaries (Figure 2E,F).
Therewasnoapparentdifferenceinthenatureoftheleuko-
cyte infiltrate between the three KO strains. After 48 h, the
proportion of polymorphonuclear leukocytes decreased in
parallel with a progressive increase in mononuclear leuko-
cytes (macrophages and lymphocytes). At 120 h after LPS
injection, there were clusters of mononuclear leukocytes
(data not shown).
Effect of LPS-induced peritonitis on NOS expression. Im-
munostaining (Figure 3) showed that LPS-induced acute
peritonitis was associated with the increased eNOS sig-
nal in the endothelium lining peritoneal blood vessels
(Figure3A,B)andincreasedimmunoreactivityfornNOSin
endothelial and perivascular inflammatory cells includingRole of NOS isoforms in LPS peritonitis 91
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Fig. 6. PD transport parameters: effect of LPS and eNOS deletion. The dialysate-to-plasma (D/P) ratio of urea (panel A) and sodium (panel C), the
progressive removal of glucose from the dialysate (D/D0 glucose; panel B) and net ultrafiltration (UF normalized to BW, panel D) were determined in
control mice (WT, open squares), eNOS WT mice treated with LPS (WT-LPS, black squares) and eNOS KO mice with LPS (KO-LPS, black triangles)
during a 2-h exchange. LPS treatment induces a major increase in the transport of urea and glucose, with a loss of sodium sieving and a loss of
ultrafiltration. All these modifications are significantly attenuated in eNOS KO mice. ∗P < 0.05 versus WT mice; #P < 0.05 versus eNOS WT-LPS
mice.
Table 2. Water and solute transport across the peritoneum in NOS isoform mice
Net UF/ Na+ D30/D0 D120/D0
NOS isoform N BW (µL/g) sieving (%) glucose glucose
eNOS
WT 5 61 ± 41 2 ± 10 . 5 9 ± 0.01 0.33 ± 0.01
WT-LPS 5 31 ± 4∗ −7 ± 1∗ 0.41 ± 0.01∗ 0.19 ± 0.01∗
KO-LPS 5 46 ± 3∗,# −2 ± 1∗,# 0.46 ± 0.02∗,# 0.23 ± 0.01∗,#
nNOS
WT 5 59 ± 41 2 ± 10 . 6 0 ± 0.01 0.32 ± 0.01
WT-LPS 5 24 ± 1∗ −4 ± 1∗ 0.47 ± 0.03∗ 0.20 ± 0.01∗
KO-LPS 4 20 ± 4∗ −5 ± 2∗ 0.45 ± 0.02∗ 0.17 ± 0.01∗
iNOS
WT 5 54 ± 21 2 ± 10 . 5 9 ± 0.01 0.32 ± 0.01
WT-LPS 4 29 ± 1∗ −4 ± 1∗ 0.48 ± 0.02∗ 0.21 ± 0.01∗
KO-LPS 5 27 ± 4∗ −4 ± 2∗ 0.49 ± 0.02∗ 0.21 ± 0.01∗
BW, body weight; UF, ultrafiltration; D120, dialysate glucose concentration at 120 min; D30, dialysate glucose concentration at 30 min; D0, dialysate
glucose concentration before the dwell.
∗P < 0.05 versus WT mice; #P < 0.05 versus WT-LPS mice.
macrophages, and nerve sections (Figure 3C–F). The LPS
treatment was also reflected by the induction of iNOS im-
munoreactivity in rare, infiltrating macrophages (data not
shown). Morphometry analysis on CD31-stained sections
confirmed that both the vascular density (in vessels/mm2:
58±10incontrolmiceversus85±16inLPS-treatedmice,
P = 0.22) and cumulative endothelial area (1.1 ± 0.4% in
control mice versus 1.6 ± 0.3% in LPS-treated mice, P =
0.33) were not significantly modified 18 h after LPS treat-
ment. Immunoblotting studies (Figure 4) demonstrated that
LPS-induced peritonitis was associated with a major up-
regulation of nNOS (155 kD) and eNOS (140 kD), and the
induction of iNOS (130 kD) in the peritoneum (Figure 4A).
Densitometry analysis confirmed that LPS treatment92 J. Ni et al.
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Fig. 7. PD transport parameters: effect of LPS and iNOS deletion. The dialysate-to-plasma (D/P) ratio of urea (A) and sodium (C), the progressive
removal of glucose from the dialysate (D/D0 glucose, B) and net ultrafiltration (UF/BW, D) were determined in control mice (WT, open squares), iNOS
WT mice treated with LPS (WT-LPS, black squares) and iNOS KO mice treated with LPS (KO-LPS, black triangles) during a 2-h exchange. Acute
peritonitis induces a major increase in the urea and glucose transport, with a loss of sodium sieving and a loss of ultrafiltration. These changes are not
modified in iNOS KO mice. ∗P < 0.05 versus WT mice.
induced an 11-fold increase in nNOS expression (relative
optical density: 1170 ± 200%, P = 0.005), and 2-fold in-
crease in eNOS expression (relative optical density: 247 ±
110%, P = 0.01) in the peritoneum (Figure 4B).
Effect of LPS on mice lacking specific NOS isoforms
Clinical and biological parameters. All mice used in the
study were similar in terms of body weight and haematocrit
(Table 1). Mice lacking eNOS, which have a higher mean
arterial blood pressure (MAP) at baseline [15,17], showed
a trend for higher MAP during acute peritonitis (Table 1).
In comparison with control mice, mice with LPS-induced
peritonitis were characterized by cloudy dialysates and sig-
nificantly increased WBC counts. Among the LPS-treated
mice,micelackingiNOSshowedsignificantlyhigherWBC
counts in the dialysate versus their wild-type littermates
(Table 1). Further examination of the visceral peritoneum
(Figure 5) revealed that the extent of inflammation induced
by LPS was significantly higher in iNOS KO versus WT
mice (inflammation score: 2.3 ± 0.3 versus 0.8 ± 0.2,
N = 5, P < 0.01). These modifications were not observed
in the eNOS and nNOS mice. The iNOS KO mice were
also characterized by a higher mortality rate following LPS
injection (mortality rate: 1/6 in iNOS WT versus 4/10 in
iNOS KO mice).
Transport parameters in mice: effects of specific NOS
deletion. The effects of LPS-induced peritonitis on trans-
port parameters were investigated in NOS KO mice, using
a 2-h PD exchange (Figures 6– 8, Table 2). This protocol
induced a progressive increase in the dialysate-to-plasma
ratio for urea (panel A), a progressive reabsorption of glu-
cose from the dialysate (panel B), a fall in the dialysate-
to-plasma ratio of sodium during the first 30 min of the
dwell (sodium sieving; panel C) and a net UF (panel D)
as previously reported [20]. Acute peritonitis induced by
LPS caused a major increase in the small solute transport
(urea and glucose), with a loss of sodium sieving and a
loss of UF in WT-LPS mice. All these modifications were
significantly attenuated in eNOS KO mice, with a partial
recovery of sodium sieving and UF, and a reduced transport
for small solutes (Figure 6, Table 2). In strong contrast,
the LPS-induced transport modifications were not signifi-
cantly modified in mice lacking iNOS (Figure 7) or nNOS
(Figure 8) (see also Table 2).
Effects of specific NOS deletion on dialysate NOx levels.
TreatmentwithLPSinduceda15-to30-foldincreaseinthe
dialysateNOxlevelsinalltypesofWTmice(Figure9).The
LPS-induced increase in NOx was significantly attenuated
in eNOS KO mice (average: −50%) and almost abolished
(average: −97%) in iNOS KO mice. These strong effectsRole of NOS isoforms in LPS peritonitis 93
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Fig. 8. PD transport parameters: effect of LPS and nNOS deletion. The dialysate-to-plasma (D/P) ratio of urea (A) and sodium (C), the progressive
removal of glucose from the dialysate (D/D0 glucose, B) and net ultrafiltration (UF/BW, D) were determined in control mice (WT, open squares), nNOS
WT mice treated with LPS (WT-LPS, black squares) and nNOS KO mice with LPS (KO-LPS, black triangles) during a 2-h exchange. Acute peritonitis
induces a major increase in the urea and glucose transport, with a loss of sodium sieving and a loss of ultrafiltration. These changes are not modified
in nNOS KO mice. ∗P < 0.05 versus WT mice.
contrasted with a mild, non-significant decrease (average:
−14%) in nNOS KO mice.
Discussion
In the present study, we provide direct evidence suggesting
thateachNOSisoformplaysadistinctroleintheperitoneal
membrane during acute peritonitis. These data are based on
the differential expression of the NOS isoforms at baseline
and during LPS-induced peritonitis, and on the character-
ization of clinical, biochemical, structural and transport
parameters in wild-type mice versus mice lacking eNOS,
iNOS and nNOS.
Several lines of evidence, obtained in rodent models and
PD patients, show that the three NOS isoforms are differ-
entially regulated according to the underlying pathogenic
process [24]. A significant upregulation of eNOS alone has
been documented in the peritoneal membrane exposed to
long-term PD [25,26]. In contrast, catheter-induced peri-
tonitis is reflected by a major increase in both eNOS and
iNOS [12–15], whereas chronic uraemia induces changes
in the expression of eNOS and nNOS [27]. The tightly
regulated pattern of expression of NOS isoforms and the
pleiotropic effects of NO raised the question of the role
played by this complex system in the peritoneal membrane
[28]. Using mouse models, we previously demonstrated the
crucial role of eNOS in the structural modifications (infil-
trate, vascular proliferation) and transport changes in acute
peritonitis [15,20]. However, these data were obtained us-
ing a 6-day model of catheter-induced bacterial peritonitis
in the single eNOS KO mouse. In contrast, the present
study was designed to decipher the specific roles of the
three NOS isoforms during the early phase of LPS-induced
acute peritonitis.
Intraperitoneal administration of LPS, an integral com-
ponent of the outer membrane of Gram-negative bacte-
ria, initiates a rapid, coordinated recruitment and activation
of leukocytes, followed by overproduction of proinflam-
matory mediators and NO [29]. Mice injected with LPS
showed cloudy dialysates with increased WBC counts and
NOxlevels,inflammatorycellinfiltratesintheperitoneum,
a major upregulation of NOS and increased transport of
small solutes with ensuing UF failure. These changes,
which are similar to those documented in other models
[12–16], are characteristic of acute peritonitis in PD pa-
tients [10,11]. The time of investigation, 18 h after LPS
injection, corresponds to the maximal release of NO. Addi-
tionoftheNOSinhibitorL-NAMEatthattimepointsignif-
icantly reversed transport modifications and NOx release
in this model [16]. Taken together, these results suggested
that the excessive release of NO may be involved in the
early changes during peritonitis. However, because NOS
inhibitors lack specificity, it has not been possible to char-
acterize the role of each NOS isoform in this acute phase
of inflammation/infection. Thus, transgenic mice lacking94 J. Ni et al.
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Fig. 9. Dialysate NOx levels: effect of eNOS, nNOS and iNOS deletion.
Treatment with LPS in WT mice induced a significant increase in NO
metabolites (NOx) in the dialysate. This effect was significantly reversed
in eNOS KO mice (top panel) and almost abolished in iNOS KO mice
(bottom panel), whereas it was unchanged in nNOS KO mice (middle
panel). ∗P < 0.05 versus WT mice; #P < 0.05 versus WT-LPS mice. N =
4 in each group.
NOSisoformsprovideanexcellenttooltoanswerthatques-
tion, using established procedures for investigation of the
peritoneal membrane [20].
Endothelium-derived NOisapotentvasodilatorthatpar-
ticipates in the regulation of blood pressure, vascular per-
meability, angiogenesis and leukocyte adhesion [30–32].
We have shown previously that mice lacking eNOS are
protected against functional and structural modifications in
a 6-day model of peritonitis [15]. The present data con-
firm and extend these findings, by showing that the lack
of eNOS significantly attenuates the acute increase in the
small solute transport induced by LPS, resulting in a sig-
nificant improvement in UF. Of note, the deletion of eNOS
does not totally reverse transport changes, as it does not
abolish the burst of NOx release in the dialysate. This
may be related to the uneven effect of LPS on the specific
NOS regulation: the 2.5-fold increase in eNOS is below the
induction of iNOS (normally absent from the peritoneum)
and the >10-fold increase in nNOS. The lack of total re-
versibility could also be due to pro-inflammatory cytokines
such as IL-6 liberated during inflammation [33] or, alterna-
tively,topost-translationalmodificationsoftargetproteins.
At variance with the 6-day catheter peritonitis model, the
upregulation of eNOS 18 h after LPS does not reflect a
significant vascular proliferation in the peritoneum. This
important difference illustrates the fact that eNOS, initially
described as a constitutive isoform, can actually be induced
by a variety of stimuli including growth factors, cytokines
and bacterial LPS [2,34]. At any rate, the upregulation of
eNOSiscriticaltoregulatetransportparametersintheearly
phase of peritonitis, which emphasizes the therapeutic po-
tential of selective inhibitors targeting this isoform.
The induction of iNOS by cytokines and proinflamma-
tory agents is known to increase NO production during
manyinflammatoryresponses,includingperitonitis[12].In
particular, LPS bind to their CD14 receptor on the surface
ofmacrophages,resultinginthetranscriptionalinductionof
iNOS with subsequent release of NO [35]. In turn, the gen-
eration of large quantities of NO by activated macrophages
maycontributetocirculatoryfailureandorganinjury.How-
ever,enhancedNOreleasemayalsoexertbeneficialeffects,
including a bactericidal effect and augmentation of host
defence [36,37]. Although it has been reported that iNOS-
deficientmiceexhibitenhancedleukocyte–endotheliumin-
teractions in endotoxaemia [38] and that iNOS activity
plays a protective role in response to inflammation [39],
the role of iNOS during acute peritonitis has not been ad-
dressed. The present study indicates that induction of iNOS
in the peritoneal membrane is a major mechanism for the
increased release of NO metabolites during the early phase
of LPS peritonitis. Mice lacking iNOS showed a nearly
complete abolition of NOx release in the dialysate despite
unchanged transport parameters, which provides a strong
argument for the local NO activity rather than increased
transport from the circulation [11]. Of note, the abolition of
NOxreleasemayalsoreflectthefactthattheexasperatedin-
flammation due to the lack of iNOS may trigger the release
of cytokines (including TNFalpha) down-regulating the ex-
pression of eNOS [40]. Furthermore, the lack of iNOS was
reflected by higher WBC counts in the dialysate, more se-
vereinflammatorychangesinthetissueandatrendtowards
increased mortality following LPS treatment. Accordingly,
it is tempting to propose that the release of NO meditated
by iNOS exerts a protective role in acute peritonitis. This
protective role may be related to host-defence mechanisms,
independently of changes in transport parameters.
The nNOS isoform plays an important role in the gen-
eration of NO for neuronal development, maturation and
neurotransmission[23,41].nNOSisalsoexpressedinextra-
neuronal cells, including neutrophils [42], endothelial cells
[43] and vascular smooth muscle cells [44]. In the peri-
toneum, nNOS is expressed in nerves and peritoneal arter-
ies, where it could play a role in uraemic neuropathy and
vasculopathy [27]. We demonstrate a 10-fold increase in
nNOS expression in the peritoneum following LPS. Like
eNOS, the expression of the ‘constitutive’ nNOS can be
regulated in response of neuronal cells to stress [2]. The
strong induction observed here appears to be related eitherRole of NOS isoforms in LPS peritonitis 95
to the time course or the nature of the stimulus. Indeed,
the 6-day model of catheter-induced peritonitis does not in-
ducenNOSexpression[12]whereasLPStreatmentinduces
nNOS expression in muscles [45]. The role of nNOS in the
peritoneum is distinct from that of eNOS and iNOS, with
a minimal effect on NOx release, and no reversibility on
transport parameters. These differences may reflect expres-
sion in distinct cellular compartments. Alternatively, one
could hypothesize that the deletion of nNOS may induce
compensatory upregulation of other NOS isoforms in the
peritoneal membrane [46]. A trend for increased dialysate
WBC counts was observed in nNOS KO mice, supporting
the hypothesis that nNOS deficiency may promote leuko-
cyte rolling and adhesion [47]. However, at variance with
iNOS, this was not reflected by changes in the severity
of inflammatory reaction to LPS. By analogy with other
models, one could hypothesize that nNOS may regulate
inflammatory pain [48] during acute peritonitis.
In summary, we have shown that the LPS-induced acute
peritonitis in the mouse is reflected by the upregulation of
the three NOS isoforms. The transport alterations induced
by peritonitis were reversed in eNOS KO mice, whereas the
inflammatory changes were more severe in iNOS KO mice.
These data give new insights in the differential roles of
NOS isoforms in the peritoneal membrane and suggest that
selective eNOS inhibition may improve peritoneal trans-
port during acute peritonitis, whereas non-specific NOS
inhibitors may impair host-defence mechanisms [49,50].
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